share_log

SenesTech | 8-K: Current report

SenesTech | 8-K: Current report

SenesTech | 8-K：重大事件
美股SEC公告 ·  06/21 04:03

Moomoo AI 已提取核心訊息

On June 20, 2024, SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, announced the entry into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC. Under this agreement, SenesTech may offer and sell shares of its common stock at its discretion in 'at the market' offerings, potentially raising aggregate gross proceeds of up to $1,575,944. The sales will be conducted pursuant to a shelf registration statement and related prospectus supplement filed with the SEC. The agreement allows Wainwright to sell shares through various methods, including directly on the Nasdaq, where SenesTech's common stock is listed under the symbol SNES. SenesTech is not obligated to sell any specific number of shares, and Wainwright will act based on SenesTech's instructions, subject to a 3.0% placement fee on the gross sales price. The offering will terminate upon reaching the maximum sales amount or by mutual termination of the agreement. The company has also provided customary indemnification rights to Wainwright and will reimburse certain expenses related to the agreement.
On June 20, 2024, SenesTech, Inc., a biotechnology company based in Phoenix, Arizona, announced the entry into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC. Under this agreement, SenesTech may offer and sell shares of its common stock at its discretion in 'at the market' offerings, potentially raising aggregate gross proceeds of up to $1,575,944. The sales will be conducted pursuant to a shelf registration statement and related prospectus supplement filed with the SEC. The agreement allows Wainwright to sell shares through various methods, including directly on the Nasdaq, where SenesTech's common stock is listed under the symbol SNES. SenesTech is not obligated to sell any specific number of shares, and Wainwright will act based on SenesTech's instructions, subject to a 3.0% placement fee on the gross sales price. The offering will terminate upon reaching the maximum sales amount or by mutual termination of the agreement. The company has also provided customary indemnification rights to Wainwright and will reimburse certain expenses related to the agreement.
2024年6月20日，總部位於亞利桑那州鳳凰城的生物技術公司SenesTech宣佈與H.C. Wainwright & Co.，LLC簽署“按市場發行協議”，SenesTech可以自行決定以“按市場”發行的方式出售普通股，可能籌集高達157萬5944美元的總募集資金。銷售將根據向SEC提交的架構註冊聲明和相關的招股書附錄而進行。協議允許Wainwright通過不同的方式出售股票，包括直接在納斯達克上銷售，其中SenesTech的普通股在SNES標的下上市。SenesTech不承諾出售任何具體數量的股票，Wainwright將根據SenesTech的指示行事，受到銷售價格總額3.0％的放置費用的約束。發行將在達到最大銷售金額或協議相互終止時終止。該公司還向Wainwright提供慣常的補償權利，並將報銷與協議相關的某些費用。
2024年6月20日，總部位於亞利桑那州鳳凰城的生物技術公司SenesTech宣佈與H.C. Wainwright & Co.，LLC簽署“按市場發行協議”，SenesTech可以自行決定以“按市場”發行的方式出售普通股，可能籌集高達157萬5944美元的總募集資金。銷售將根據向SEC提交的架構註冊聲明和相關的招股書附錄而進行。協議允許Wainwright通過不同的方式出售股票，包括直接在納斯達克上銷售，其中SenesTech的普通股在SNES標的下上市。SenesTech不承諾出售任何具體數量的股票，Wainwright將根據SenesTech的指示行事，受到銷售價格總額3.0％的放置費用的約束。發行將在達到最大銷售金額或協議相互終止時終止。該公司還向Wainwright提供慣常的補償權利，並將報銷與協議相關的某些費用。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間